Riskpilot← Back to searchSign inGet full accessZYMINVEST AS
ASActiveOrg 989586300Østerøyveien 255, 3237 SandefjordRental and operating of own or leased real estate · NACE 6820Est. 20060 employees
Revenue 2024
NOK 0
EBITDA margin
—
+87% vs 2023
Equity ratio
-2037.3%
Financial strength
Net profit 2024
NOK -18K
-80% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -1K | +87% |
| Net profit | NOK -18K | -80% |
| Total assets | NOK 38K | -1% |
| Equity | NOK -772K | -2% |
| Employees | 0 | — |
Legal name
ZYMINVEST AS
Org number
989586300
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
18. mars 2006
Share capital
NOK 39 246
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder alene.
Company purpose
Handel med og investering i fast eiendom, verdipapirer og andre formuesobjekter, herunder deltakelse i andre selskaper med lignende virksomhet.
Address
Østerøyveien 255, 3237 Sandefjord
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −7 | −7 | −9 | −10 | −1 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −7 | −7 | −9 | −10 | −1 |
| Net financials | 0 | 0 | 0 | 0 | −17 |
| Profit before tax | −7 | −7 | −9 | −10 | −18 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −7 | −7 | −9 | −10 | −18 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 63 | 38 | 38 | 38 | 38 |
| Equity | −728 | −735 | −743 | −754 | −772 |
| Long-term debt | 720 | 734 | 742 | 751 | 769 |
| Short-term debt | 70 | 39 | 39 | 41 | 41 |
| Total debt | 790 | 773 | 782 | 792 | 810 |
EBITDA margin
-134000.0%
This company
15.8%
Market median
-848201% vs market
20202024
Equity ratio
-2037.3%
This company
38.2%
Market median
-5433% vs market
20202024
Return on equity
-1820800.0%
This company
18.4%
Market median
-9895752% vs market
20202024
Net profit margin
-1820800.0%
This company
8.1%
Market median
-22479112% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.05×
This company
0.62×
Market median
-69% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EF Chief Executive Officer | Chief Executive Officer | 2011 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2017 | |
| Former (2) | ||
| Board of Directors | 2017 – 2017 | |
| Board of Directors | 2017 – 2017 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 40.47% | 40.47% | 2022 | |
| Company | 22.12% | 22.12% | 2022 | |
| Company | 22.12% | 22.12% | 2022 | |
| Company | 7.64% | 7.64% | 2022 | |
| Company | 7.64% | 7.64% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Time Recorder Co As
ZYMINVEST AS Board members of ZYMINVEST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Einar Frogner | Chief Executive Officer | 0 companies |
| John Arthur Olafsen | Chairman | 0 companies |
| Kåre Krogstad | Board of Directors | 0 companies |
| Terje Haanes | Board of Directors | 0 companies |